BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 22046087)

  • 1. Association of overexpression of TIF1γ with colorectal carcinogenesis and advanced colorectal adenocarcinoma.
    Jain S; Singhal S; Francis F; Hajdu C; Wang JH; Suriawinata A; Wang YQ; Zhang M; Weinshel EH; Francois F; Pei ZH; Lee P; Xu RL
    World J Gastroenterol; 2011 Sep; 17(35):3994-4000. PubMed ID: 22046087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of transforming growth factor beta (TGF-β) signaling axis molecules and E-cadherin in colorectal cancer.
    Lampropoulos P; Zizi-Sermpetzoglou A; Rizos S; Kostakis A; Nikiteas N; Papavassiliou AG
    Tumour Biol; 2012 Aug; 33(4):1005-14. PubMed ID: 22278155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of TGF-beta1, its receptor TGFbetaRII, and Smad proteins in the progression of colorectal cancer.
    Gulubova M; Manolova I; Ananiev J; Julianov A; Yovchev Y; Peeva K
    Int J Colorectal Dis; 2010 May; 25(5):591-9. PubMed ID: 20165854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TIF1γ interferes with TGFβ1/SMAD4 signaling to promote poor outcome in operable breast cancer patients.
    Kassem L; Deygas M; Fattet L; Lopez J; Goulvent T; Lavergne E; Chabaud S; Carrabin N; Chopin N; Bachelot T; Gillet G; Treilleux I; Rimokh R
    BMC Cancer; 2015 Jun; 15():453. PubMed ID: 26040677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TIF1γ and SMAD4 regulation in colorectal cancer: impact on cell proliferation and liver metastasis.
    Wu Y; Yu B; Ai X; Zhang W; Chen W; Laurence A; Zhang M; Chen Q; Shao Y; Zhang B
    Biol Chem; 2024 Apr; 405(4):241-256. PubMed ID: 38270141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concordant repression and aberrant methylation of transforming growth factor-beta signaling pathway genes occurs early in gastric cardia adenocarcinoma.
    Guo W; Dong Z; Guo Y; Kuang G; Yang Z; Shan B
    Mol Biol Rep; 2012 Oct; 39(10):9453-62. PubMed ID: 22722999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antimetastatic role of Smad4 signaling in colorectal cancer.
    Zhang B; Halder SK; Kashikar ND; Cho YJ; Datta A; Gorden DL; Datta PK
    Gastroenterology; 2010 Mar; 138(3):969-80.e1-3. PubMed ID: 19909744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Smad4 overexpression in hepatocellular carcinoma is strongly associated with transforming growth factor beta II receptor immunolabeling.
    Torbenson M; Marinopoulos S; Dang DT; Choti M; Ashfaq R; Maitra A; Boitnott J; Wilentz RE
    Hum Pathol; 2002 Sep; 33(9):871-6. PubMed ID: 12378510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Smad4-mediated signaling inhibits intestinal neoplasia by inhibiting expression of β-catenin.
    Freeman TJ; Smith JJ; Chen X; Washington MK; Roland JT; Means AL; Eschrich SA; Yeatman TJ; Deane NG; Beauchamp RD
    Gastroenterology; 2012 Mar; 142(3):562-571.e2. PubMed ID: 22115830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting the ERK pathway reduces liver metastasis of Smad4-inactivated colorectal cancer.
    Ai X; Wu Y; Zhang W; Zhang Z; Jin G; Zhao J; Yu J; Lin Y; Zhang W; Liang H; Datta PK; Zhang M; Zhang B; Chen X
    Cancer Biol Ther; 2013 Nov; 14(11):1059-67. PubMed ID: 24025354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Expression of Smad4 and transforming growth factor-beta1, transforming growth factor-beta receptor II in cholangiocarcinoma tissue and its biological significance].
    Zhang BY; Zhang JY; Zhao K; Wu LQ
    Zhonghua Wai Ke Za Zhi; 2005 Jul; 43(13):846-9. PubMed ID: 16083599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of SMAD4 from colorectal cancer cells promotes CCL15 expression to recruit CCR1+ myeloid cells and facilitate liver metastasis.
    Itatani Y; Kawada K; Fujishita T; Kakizaki F; Hirai H; Matsumoto T; Iwamoto M; Inamoto S; Hatano E; Hasegawa S; Maekawa T; Uemoto S; Sakai Y; Taketo MM
    Gastroenterology; 2013 Nov; 145(5):1064-1075.e11. PubMed ID: 23891973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nuclear localization of Dpc4 (Madh4, Smad4) in colorectal carcinomas and relation to mismatch repair/transforming growth factor-beta receptor defects.
    Montgomery E; Goggins M; Zhou S; Argani P; Wilentz R; Kaushal M; Booker S; Romans K; Bhargava P; Hruban R; Kern S
    Am J Pathol; 2001 Feb; 158(2):537-42. PubMed ID: 11159190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gasdermin C Is Upregulated by Inactivation of Transforming Growth Factor β Receptor Type II in the Presence of Mutated Apc, Promoting Colorectal Cancer Proliferation.
    Miguchi M; Hinoi T; Shimomura M; Adachi T; Saito Y; Niitsu H; Kochi M; Sada H; Sotomaru Y; Ikenoue T; Shigeyasu K; Tanakaya K; Kitadai Y; Sentani K; Oue N; Yasui W; Ohdan H
    PLoS One; 2016; 11(11):e0166422. PubMed ID: 27835699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dynamic regulation of Tgf-B signaling by Tif1γ: a computational approach.
    Andrieux G; Fattet L; Le Borgne M; Rimokh R; Théret N
    PLoS One; 2012; 7(3):e33761. PubMed ID: 22461896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced expression of transcriptional intermediary factor 1 gamma promotes metastasis and indicates poor prognosis of hepatocellular carcinoma.
    Ding ZY; Jin GN; Wang W; Chen WX; Wu YH; Ai X; Chen L; Zhang WG; Liang HF; Laurence A; Zhang MZ; Datta PK; Zhang B; Chen XP
    Hepatology; 2014 Nov; 60(5):1620-36. PubMed ID: 24954480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of Smad4 and TGF-beta2 in colorectal carcinoma.
    Kouvidou Ch; Latoufis C; Lianou E; Kouvatseas G; Kakouri E; Anagnostakis D; Vrettou-Aravani V; Betsi E; Karatapanis S
    Anticancer Res; 2006; 26(4B):2901-7. PubMed ID: 16886611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SMAD4/DPC4 expression and prognosis in human colorectal cancer.
    Isaksson-Mettävainio M; Palmqvist R; Forssell J; Stenling R; Oberg A
    Anticancer Res; 2006; 26(1B):507-10. PubMed ID: 16739311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antagonistic regulation of EMT by TIF1γ and Smad4 in mammary epithelial cells.
    Hesling C; Fattet L; Teyre G; Jury D; Gonzalo P; Lopez J; Vanbelle C; Morel AP; Gillet G; Mikaelian I; Rimokh R
    EMBO Rep; 2011 Jul; 12(7):665-72. PubMed ID: 21597466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of transforming growth factor-beta signaling pathway in pathogenesis of benign biliary stricture.
    Geng ZM; Zheng JB; Zhang XX; Tao J; Wang L
    World J Gastroenterol; 2008 Aug; 14(31):4949-54. PubMed ID: 18756605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.